111 related articles for article (PubMed ID: 19883162)
1. The VP1-unique region of parvovirus B19 induces myocardial injury in mice.
Nie X; Zhang G; Xu D; Sun X; Li Z; Li X; Zhang X; He F; Li Y
Scand J Infect Dis; 2010; 42(2):121-8. PubMed ID: 19883162
[TBL] [Abstract][Full Text] [Related]
2. Increased cardiac injury in NZB/W F1 mice received antibody against human parvovirus B19 VP1 unique region protein.
Tzang BS; Lin TM; Tsai CC; Hsu JD; Yang LC; Hsu TC
Mol Immunol; 2011 Jul; 48(12-13):1518-24. PubMed ID: 21555155
[TBL] [Abstract][Full Text] [Related]
3. Human parvovirus B19 VP1u Protein as inflammatory mediators induces liver injury in naïve mice.
Hsu TC; Chiu CC; Chang SC; Chan HC; Shi YF; Chen TY; Tzang BS
Virulence; 2016; 7(2):110-8. PubMed ID: 26632342
[TBL] [Abstract][Full Text] [Related]
4. Induction of antiphospholipid antibodies and antiphospholipid syndrome-like autoimmunity in naive mice with antibody against human parvovirus B19 VP1 unique region protein.
Tzang BS; Lee YJ; Yang TP; Tsay GJ; Shi JY; Tsai CC; Hsu TC
Clin Chim Acta; 2007 Jul; 382(1-2):31-6. PubMed ID: 17451664
[TBL] [Abstract][Full Text] [Related]
5. A Novel Murine Model of Parvovirus Associated Dilated Cardiomyopathy Induced by Immunization with VP1-Unique Region of Parvovirus B19.
Bogomolovas J; Šimoliūnas E; Rinkūnaitė I; Smalinskaitė L; Podkopajev A; Bironaitė D; Weis CA; Marx A; Bukelskienė V; Gretz N; Grabauskienė V; Labeit D; Labeit S
Biomed Res Int; 2016; 2016():1627184. PubMed ID: 27812527
[No Abstract] [Full Text] [Related]
6. The VP1 unique region of human parvovirus B19 and human bocavirus induce lung injury in naïve Balb/c mice.
Lin CY; Chung YH; Shi YF; Tzang BS; Hsu TC
PLoS One; 2018; 13(8):e0202667. PubMed ID: 30114253
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of adhesion molecule expression and induction of TNF-alpha on vascular endothelial cells by antibody against human parvovirus B19 VP1 unique region protein.
Tzang BS; Tsai CC; Chiu CC; Shi JY; Hsu TC
Clin Chim Acta; 2008 Sep; 395(1-2):77-83. PubMed ID: 18538665
[TBL] [Abstract][Full Text] [Related]
8. Conformational changes in the VP1-unique region of native human parvovirus B19 lead to exposure of internal sequences that play a role in virus neutralization and infectivity.
Ros C; Gerber M; Kempf C
J Virol; 2006 Dec; 80(24):12017-24. PubMed ID: 17020940
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis.
Kuethe F; Lindner J; Matschke K; Wenzel JJ; Norja P; Ploetze K; Schaal S; Kamvissi V; Bornstein SR; Schwanebeck U; Modrow S
Clin Infect Dis; 2009 Dec; 49(11):1660-6. PubMed ID: 19863443
[TBL] [Abstract][Full Text] [Related]
10. The N-terminal 5-68 amino acids domain of the minor capsid protein VP1 of human parvovirus B19 enters human erythroid progenitors and inhibits B19 infection.
Zou W; Ning K; Xu P; Deng X; Cheng F; Kleiboeker S; Qiu J
J Virol; 2021 Jun; 95(14):. PubMed ID: 33952637
[TBL] [Abstract][Full Text] [Related]
11. The association of VP1 unique region protein in acute parvovirus B19 infection and anti-phospholipid antibody production.
Tzang BS; Tsay GJ; Lee YJ; Li C; Sun YS; Hsu TC
Clin Chim Acta; 2007 Mar; 378(1-2):59-65. PubMed ID: 17169353
[TBL] [Abstract][Full Text] [Related]
12. Effect of the Functional VP1 Unique Region of Human Parvovirus B19 in Causing Skin Fibrosis of Systemic Sclerosis.
Chen DY; Tzang CC; Liu CM; Chiu TM; Lin JW; Chuang PH; Kuo CW; Tzang BS; Hsu TC
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894973
[TBL] [Abstract][Full Text] [Related]
13. The effects of human parvovirus VP1 unique region in a mouse model of allergic asthma.
Chiang SR; Lin CY; Chen DY; Tsai HF; Lin XC; Hsu TC; Tzang BS
PLoS One; 2019; 14(5):e0216799. PubMed ID: 31086415
[TBL] [Abstract][Full Text] [Related]
14. Parvovirus B19 profiles in patients presenting with acute myocarditis and chronic dilated cardiomyopathy.
Escher F; Modrow S; Sabi T; Kühl U; Lassner D; Schultheiss HP; Noutsias M
Med Sci Monit; 2008 Dec; 14(12):CR589-97. PubMed ID: 19043365
[TBL] [Abstract][Full Text] [Related]
15. The Receptor-Binding Domain in the VP1u Region of Parvovirus B19.
Leisi R; Di Tommaso C; Kempf C; Ros C
Viruses; 2016 Feb; 8(3):61. PubMed ID: 26927158
[TBL] [Abstract][Full Text] [Related]
16. Parvovirus B19 uptake is a highly selective process controlled by VP1u, a novel determinant of viral tropism.
Leisi R; Ruprecht N; Kempf C; Ros C
J Virol; 2013 Dec; 87(24):13161-7. PubMed ID: 24067971
[TBL] [Abstract][Full Text] [Related]
17. The association of anti-parvovirus B19-VP1 unique region antibodies with antiphospholipid antibodies in patients with antiphospholipid syndrome.
Chen DY; Tzang BS; Chen YM; Lan JL; Tsai CC; Hsu TC
Clin Chim Acta; 2010 Aug; 411(15-16):1084-9. PubMed ID: 20385113
[TBL] [Abstract][Full Text] [Related]
18. Antigenicity analysis of human parvovirus B19-VP1u protein in the induction of anti-phospholipid syndrome.
Lin CY; Chiu CC; Cheng J; Lin CY; Shi YF; Tsai CC; Tzang BS; Hsu TC
Virulence; 2018 Jan; 9(1):208-216. PubMed ID: 28960143
[TBL] [Abstract][Full Text] [Related]
19. Interaction of parvovirus B19 with human erythrocytes alters virus structure and cell membrane integrity.
Bönsch C; Kempf C; Ros C
J Virol; 2008 Dec; 82(23):11784-91. PubMed ID: 18815302
[TBL] [Abstract][Full Text] [Related]
20. The VP1u of Human Parvovirus B19: A Multifunctional Capsid Protein with Biotechnological Applications.
Ros C; Bieri J; Leisi R
Viruses; 2020 Dec; 12(12):. PubMed ID: 33352888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]